My first entry into RAN was in April 2018 at around 3 cents. Later, in May, I wrote on this forum, "It's all about sales". I was highlighting that without sales, the best ideas in the world can prove fruitless.
So now the idea has been refined, commercially and financially capable people have replaced the old management while productivity improves. Finally, it now appears that we are on the launching pad of increased sales at a higher unit price. Initially, the target of US$5 million of sales for 2022 must be considered possible, and in 2023, maybe US$10 million. Management has reaffirmed that substantial upside operating leverage exists in this business, and therefore as sales increase, profits will increase faster.
What is a reasonable MC for a high growth manufacturing company, notably in the ESG space, where its product is facing severe structural shortages?
My answer. I agree with @Tian8824. A$13 million is crazy cheap.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
RAN
range international limited
Add to My Watchlist
0.00%
!
0.2¢

My first entry into RAN was in April 2018 at around 3 cents....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.878M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2070004 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.002 |
23 | 50444769 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2070004 | 6 |
0.004 | 1155263 | 3 |
0.005 | 2454695 | 3 |
0.006 | 2185526 | 2 |
0.007 | 244444 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online